The weight of obesity in hypertrophic cardiomyopathy.

BMI bariatric disease modifiers hypertrophic cardiomyopathy obesity

Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 14 4 2024
pubmed: 14 4 2024
entrez: 13 4 2024
Statut: ppublish

Résumé

Hypertrophic cardiomyopathy is one of the most frequently diagnosed primary conditions of the heart muscle. It is considered to be inherited, caused by genetic mutations encoding for sarcomere proteins. The marked heterogeneity in clinical manifestations and natural course of the disease, even among family members sharing the same genetic mutation, has raised the question of non-genetic environmental factors contributing to the phenotype. Obesity has been associated with worse cardiovascular outcomes in the general population. Its prevalence is increased in hypertrophic cardiomyopathy, and the two conditions share some similar pathophysiological and clinical characteristics. In this review, we aim to summarise the effects of obesity in the cardiac phenotype, the symptoms and management in patients with hypertrophic cardiomyopathy.

Identifiants

pubmed: 38614650
pii: S1470-2118(24)04583-4
doi: 10.7861/clinmed.2023-0194
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-363

Informations de copyright

Copyright © 2023 © 2023 THE AUTHORS. Published by Elsevier Limited on behalf of the Royal College of Physicians. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Marina Zaromytidou (M)

Barts Health NHS Trust, London, UK. Electronic address: marina.zaromytidou@nhs.net.

Konstantinos Savvatis (K)

Barts Health NHS Trust, London, UK; William Harvey Research Institute, Queen Mary University London, UK; Institute for Cardiovascular Science, University College London, London, UK.

Classifications MeSH